369593-42-0 Usage
Description
(R)-Hesperidin, a flavonoid compound predominantly found in citrus fruits like oranges and lemons, is celebrated for its robust antioxidant and anti-inflammatory properties. It is widely recognized in herbal medicine for its potential health benefits, which include enhancing blood circulation, mitigating inflammation, and diminishing the risk of heart disease. Furthermore, (R)-hesperidin has been explored for its capacity to shield against neurodegenerative diseases and bolster cognitive function. Its potential to foster skin health and defend against UV radiation damage adds to its allure. Given its extensive range of potential health benefits, (R)-hesperidin stands as a promising natural compound for further investigation and advancement in the realms of medicine and nutraceuticals.
Uses
Used in Pharmaceutical Applications:
(R)-Hesperidin is utilized as a therapeutic agent for its potential to improve blood circulation, reduce inflammation, and lower the risk of heart disease. Its antioxidant and anti-inflammatory properties make it a valuable asset in the treatment and prevention of various health conditions.
Used in Neuroprotective Applications:
(R)-Hesperidin is employed as a neuroprotective agent due to its potential to protect against neurodegenerative diseases and improve cognitive function. Its antioxidant properties contribute to its effectiveness in safeguarding the brain and nervous system.
Used in Skincare Applications:
(R)-Hesperidin is used as an ingredient in skincare products for its potential to promote skin health and protect against UV radiation damage. Its antioxidant properties aid in maintaining skin integrity and resilience.
Used in Nutraceutical Applications:
(R)-Hesperidin is used as a key component in the development of nutraceutical products, capitalizing on its diverse range of potential health benefits. Its antioxidant and anti-inflammatory properties, along with its potential to enhance blood circulation and cognitive function, make it a sought-after ingredient in the nutraceutical industry.
Check Digit Verification of cas no
The CAS Registry Mumber 369593-42-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,6,9,5,9 and 3 respectively; the second part has 2 digits, 4 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 369593-42:
(8*3)+(7*6)+(6*9)+(5*5)+(4*9)+(3*3)+(2*4)+(1*2)=200
200 % 10 = 0
So 369593-42-0 is a valid CAS Registry Number.
369593-42-0Relevant articles and documents
Preparation and evaluation of a triazole-bridged bis(β-cyclodextrin)–bonded chiral stationary phase for HPLC
Shuang, Yazhou,Liao, Yuqin,Wang, Hui,Wang, Yuanxing,Li, Laisheng
, p. 168 - 184 (2019/11/25)
A triazole-bridged bis(β-cyclodextrin) was synthesized via a high-yield Click Chemistry reaction between 6-azido-β-cyclodextrin and 6-propynylamino-β-cyclodextrin, and then it was bonded onto ordered silica gel SBA-15 to obtain a novel triazole-bridged bis (β-cyclodextrin)–bonded chiral stationary phase (TBCDP). The structures of the bridged cyclodextrin and TBCDP were characterized by the infrared spectroscopy, mass spectrometry, elemental analysis, and thermogravimetric analysis. The chiral performance of TBCDP was evaluated by using chiral pesticides and drugs as probes including triazoles, flavanones, dansyl amino acids and β-blockers. Some effects of the composition in mobile phase and pH value on the enantioseparations were investigated in different modes. The nine triazoles, eight flavanones, and eight dansyl amino acids were successfully resolved on TBCDP under the reversed phase with the resolutions of hexaconazole, 2′-hydroxyflavanone, and dansyl-DL-tyrosine, which were 2.49, 5.40, and 3.25 within 30 minutes, respectively. The ten β-blockers were also separated under the polar organic mode with the resolution of arotinolol reached 1.71. Some related separation mechanisms were discussed preliminary. Compared with the native cyclodextrin stationary phase (CDSP), TBCDP has higher enantioselectivity to separate more analytes, which benefited from the synergistic inclusion ability of the two adjacent cavities and bridging linker of TBCDP, thereby enabling it a promising prospect in chiral drugs and food analysis.
